Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ealing, J.
Right arrow Articles by Beeson, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ealing, J.
Right arrow Articles by Beeson, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2002, Vol. 11, No. 24 3087-3096
© 2002 Oxford University Press

Mutations in congenital myasthenic syndromes reveal an {varepsilon} subunit C-terminal cysteine, C470, crucial for maturation and surface expression of adult AChR

John Ealing1, Richard Webster1, Sharon Brownlow1, Amr Abdelgany1, Hans Oosterhuis2,{dagger}, Francesco Muntoni3, David J. Vaux4, Angela Vincent1 and David Beeson1,*

1Neurosciences Group, Weatherall Institute of Molecular Medicine, The John Radcliffe, Oxford OX3 9DS, UK, 2The Department of Neurology, Academic Hospital, Groningen, The Netherlands, 3Department of Paediatrics, Imperial College, London, UK and 4Sir William Dunn School of Pathology, University of Oxford, UK

Received August 5, 2002; Accepted September 25, 2002

Many congenital myasthenic syndromes (CMS) are associated with mutations in the genes encoding the acetylcholine receptor (AChR), an oligomeric protein with the structure {alpha}2ß{delta}{varepsilon}. AChR deficiency is frequently due to homozygous or heteroallelic mutations in the AChR {varepsilon} subunit, most of which cause truncation of the polypeptide chain and loss of surface expression of AChR. Here we identified mutations {varepsilon}1369delG and {varepsilon}Y458X, located in the 18 amino acid {varepsilon} subunit C-terminus that lies extracellular to the M4 transmembrane domain. We then incorporated green fluorescent protein (GFP) into the intracellular loop between M3 and M4 of mutant or wild-type {varepsilon} subunits and expressed the AChRs in RD or HEK 293 cells. AChR containing wild-type GFP-tagged {varepsilon} subunits were incorporated into the surface membrane, whereas the GFP-tagged AChR mutant {varepsilon} subunits co-localized with an endoplasmic reticulum (ER) marker and were not expressed on the cell surface. In addition, mutant AChRs did not reach the cell surface, as measured by labelling of intact cells with 125I-{alpha}-bungarotoxin and precipitation with an {varepsilon}-subunit-specific antiserum. Mutagenesis studies showed that cysteine 470, located four amino acids from the C-terminus, is essential for {alpha}/{varepsilon} assembly and surface expression of adult AChR. Replacement of cysteine 470 by serine does not restore {alpha}/{varepsilon} assembly or surface expression. Our results provide the first use of GFP-tagged AChR as a tool for investigation of CMS and demonstrate a previously undetermined role for a disulphide-bonded cystine in the {varepsilon} subunit C-terminus, which plays a crucial role in expression of the adult AChR.

* To whom correspondence should be addressed: Tel: +44 1865222311; Fax: +44 1865222402; Email: dbeeson{at}hammer.imm.ox.ac.uk

{dagger} Deceased May 2002.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Med. Genet.Home page
P Richard, K Gaudon, F Andreux, E Yasaki, C Prioleau, S Bauche, A Barois, C Ioos, M Mayer, M C Routon, et al.
Possible founder effect of rapsyn N88K mutation and identification of novel rapsyn mutations in congenital myasthenic syndromes
J. Med. Genet., June 1, 2003; 40(6): e81 - 81.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.